Audiovestibular adverse events following COVID-19 vaccinations

CONCLUSIONS: This study is the first to demonstrate an increase in general practice presentations of vertigo following mRNA vaccines (RI = 1.40, P <.001), and tinnitus following both the Vaxzevria® adenovirus vector and mRNA vaccines (RI = 2.25, P <.001 and 1.53, P <.001 respectively). There was no increase in hearing loss following any COVID-19 vaccinations. Our study, however, was unable to account for the potential of concurrent COVID-19 infections, which literature has indicated to be associated with audiovestibular events. Healthcare providers and vaccinees should be alert to potential audiovestibular complaints after COVID-19 vaccination. Our analysis highlights the importance of using large real-world datasets to gather reliable evidence for public health decision making.PMID:38395721 | DOI:10.1016/j.vaccine.2024.02.051

Source: Vaccine - February 23, 2024 Category: Allergy & Immunology Authors: Aishwarya N Shetty Hannah J Morgan Linny K Phuong John Mallard Diana Vlasenko Christopher Pearce Nigel W Crawford Jim P Buttery Hazel J Clothier Source Type: research